US2018015117A1PendingUtilityA1
Method for prevention of colectomy
Est. expiryNov 25, 2031(~5.4 yrs left)· nominal 20-yr term from priority
A61P 37/02A61P 37/00A61P 1/04C12N 2310/17A61K 45/06A61K 31/713C12N 15/117C12N 2320/31A61K 39/0005C12N 2310/315
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating chronic active ulcerative colitis in a subject that is refractory or responds insufficiently or is intolerant to anti-inflammatory therapy, comprises administering to a patient in need thereof an effective exposure of an oligonucleotide comprising the sequence 5′-GGAACAGTTCGTCCATGGC-3′ (SEQ ID NO.2), wherein at least one CG dinucleotide is unmethylated. The oligonucleotide is not administered with corticosteroids or glucocorticosteroids.
Claims
exact text as granted — not AI-modified1 . A method of treating chronic active ulcerative colitis in a subject that is refractory or responds insufficiently or is intolerant to anti-inflammatory therapy, comprising administering to a patient in need thereof an effective exposure of an oligonucleotide comprising the sequence 5′-GGAACAGTTCGTCCATGGC-3′ (SEQ ID NO.2), wherein at least one CG dinucleotide is unmethylated, and wherein said oligonucleotide is not administered with corticosteroids or glucocorticosteroids.
Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.